How big is the RNA analysis market?

The global RNA analysis market size was estimated at USD 8.62 billion in 2024 and is expected to reach USD 9.19 billion in 2025.

What is the RNA analysis market growth?

The global RNA analysis market is expected to grow at a compound annual growth rate of 12.55% from 2025 to 2033 to reach USD 23.65 billion by 2033.

Which segment accounted for the largest RNA analysis market share?

North America dominated the RNA analysis market with a share of 43.49% in 2024. This is attributable to increasing market activities by U.S.-based companies to translate transcriptomics insights into clinical practices.

Who are the key players in the RNA analysis market?

Some key players operating in the RNA analysis market include Agilent Technologies; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; QIAGEN; Thermo Fisher Scientific, Inc.; Eurofins Scientific; Merck KGaA; Pacific Bioscience of California, Inc.; Affymetrix, Inc.; Danaher; Promega

What are the factors driving the RNA analysis market?

Key factors that are driving the RNA analysis market growth include increasing interest of research entities in studying the transcriptomic profiles of humans and growing knowledge on the role of transcriptomics in disease diagnosis.